ERBB2 c.2329G>C ;(p.V777L)

Variant ID: 17-37881000-G-C

NM_004448.2(ERBB2):c.2329G>C;(p.V777L)

This variant was identified in 165 publications

View GRCh38 version.




Publications:


Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer.

Npj Breast Cancer
Pegram, Mark M; Jackisch, Christian C; Johnston, Stephen R D SRD
Publication Date: 2023-05-31

Variant appearance in text: ERBB2: V777L
PubMed Link: 37258523
Variant Present in the following documents:
  • Main text
  • 41523_2023_Article_533.pdf
View BVdb publication page



Ado-tratuzumab emtansine beyond breast cancer: therapeutic role of targeting other HER2-positive cancers.

Frontiers In Molecular Biosciences
Zheng, Yang Y; Zou, Jiayu J; Sun, Chen C; Peng, Fu F; Peng, Cheng C
Publication Date: 2023

Variant appearance in text: HER2: V777L
PubMed Link: 37251081
Variant Present in the following documents:
  • Main text
  • fmolb-10-1165781.pdf
View BVdb publication page



The Role of HER2 Status in the Biliary Tract Cancers.

Cancers
Ayasun, Ruveyda R; Ozer, Muhammet M; Sahin, Ilyas I
Publication Date: 2023-05-05

Variant appearance in text: HER2: V777L
PubMed Link: 37174094
Variant Present in the following documents:
  • Main text
  • cancers-15-02628.pdf
View BVdb publication page



Pan-cancer whole-genome comparison of primary and metastatic solid tumours.

Nature
Martínez-Jiménez, Francisco F; Movasati, Ali A; Brunner, Sascha Remy SR; Nguyen, Luan L; Priestley, Peter P; Cuppen, Edwin E; Van Hoeck, Arne A
Publication Date: 2023-05-10

Variant appearance in text: ERBB2: V777L
PubMed Link: 37165194
Variant Present in the following documents:
  • 41586_2023_6054_MOESM1_ESM.pdf
  • 41586_2023_6054_MOESM12_ESM.xlsx, sheet 5
  • 41586_2023_6054_MOESM3_ESM.pdf
View BVdb publication page



A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression.

Cancer Cell
Hutten, Stefan J SJ; de Bruijn, Roebi R; Lutz, Catrin C; Badoux, Madelon M; Eijkman, Timo T; Chao, Xue X; Ciwinska, Marta M; Sheinman, Michael M; Messal, Hendrik H; Herencia-Ropero, Andrea A; Kristel, Petra P; Mulder, Lennart L; van der Waal, Rens R; Sanders, Joyce J; Almekinders, Mathilde M MM; Llop-Guevara, Alba A; Davies, Helen R HR; van Haren, Matthijs J MJ; Martin, Nathaniel I NI; Behbod, Fariba F; Nik-Zainal, Serena S; Serra, Violeta V; van Rheenen, Jacco J; Lips, Esther H EH; Wessels, Lodewyk F A LFA; , ; Wesseling, Jelle J; Scheele, Colinda L G J CLGJ; Jonkers, Jos J
Publication Date: 2023-04-24

Variant appearance in text: N/A
PubMed Link: 37116492
Variant Present in the following documents:
View BVdb publication page



Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer.

Frontiers In Oncology
Han, Yanjie Y; Xiong, Yuanyuan Y; Lu, Tao T; Chen, Rongrong R; Liu, Yuan Y; Tang, Hui H; Geng, Ruixuan R; Wang, Yingyi Y
Publication Date: 2023

Variant appearance in text: HER2: V777L
PubMed Link: 37077822
Variant Present in the following documents:
  • fonc-13-1121708.pdf
View BVdb publication page



Molecular profiling of colorectal cancer in a genetically admixed Hispanic population.

Cancer Medicine
Montes-Rodríguez, Ingrid M IM; Centeno-Girona, Hilmaris H; Rivera-Lynch, Camila C; Rivera, Noridza N; Cruz-Correa, Marcia M
Publication Date: 2023-04-11

Variant appearance in text: ERBB2: V777L
PubMed Link: 37039257
Variant Present in the following documents:
  • Main text
  • CAM4-12-11686.pdf
  • CAM4-12-11686-s002.xlsx, sheet 1
View BVdb publication page



Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial.

Cell Research
Liu, Yin Y; Zhu, Xiu-Zhi XZ; Xiao, Yi Y; Wu, Song-Yang SY; Zuo, Wen-Jia WJ; Yu, Qiang Q; Cao, A-Yong AY; Li, Jun-Jie JJ; Yu, Ke-Da KD; Liu, Guang-Yu GY; Wu, Jiong J; Sun, Tao T; Cui, Jiu-Wei JW; Lv, Zheng Z; Li, Hui-Ping HP; Zhu, Xiao-Yu XY; Jiang, Yi-Zhou YZ; Wang, Zhong-Hua ZH; Shao, Zhi-Ming ZM
Publication Date: 2023-03-27

Variant appearance in text: ERBB2: V777L
PubMed Link: 36973538
Variant Present in the following documents:
  • 41422_2023_795_MOESM1_ESM.pdf
View BVdb publication page



Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution.

Cancers
Giugliano, Federica F; Carnevale Schianca, Ambra A; Corti, Chiara C; Ivanova, Mariia M; Bianco, Nadia N; Dellapasqua, Silvia S; Criscitiello, Carmen C; Fusco, Nicola N; Curigliano, Giuseppe G; Munzone, Elisabetta E
Publication Date: 2023-02-22

Variant appearance in text: HER2: V777L
PubMed Link: 36900178
Variant Present in the following documents:
  • Main text
  • cancers-15-01385.pdf
View BVdb publication page



Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value.

British Journal Of Cancer
Franken, André A; Kraemer, Annika A; Sicking, Alicia A; Watolla, Meike M; Rivandi, Mahdi M; Yang, Liwen L; Warfsmann, Jens J; Polzer, Bernhard M BM; Friedl, Thomas W P TWP; Meier-Stiegen, Franziska F; Stoecklein, Nikolas H NH; Dayan, Davut D; Riethdorf, Sabine S; Mueller, Volkmar V; Pantel, Klaus K; Koch, André A; Hartkopf, Andreas D AD; Krawczyk, Natalia N; Ruckhaeberle, Eugen E; Niederacher, Dieter D; Fehm, Tanja T; Neubauer, Hans H
Publication Date: 2023-02-23

Variant appearance in text: ERBB2: V777L
PubMed Link: 36823365
Variant Present in the following documents:
  • Main text
  • 41416_2023_Article_2179.pdf
View BVdb publication page



Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer.

Nature Communications
Shi, Wenhao W; Wang, Yushen Y; Xu, Chen C; Li, Yan Y; Ge, Sai S; Bai, Bin B; Zhang, Kecheng K; Wang, Yunzhi Y; Zheng, Nairen N; Wang, Juan J; Wang, Shiqi S; Ji, Gang G; Li, Jipeng J; Nie, Yongzhan Y; Liang, Wenquan W; Wu, Xiaosong X; Cui, Jianxin J; Wang, Yi Y; Chen, Lin L; Zhao, Qingchuan Q; Shen, Lin L; He, Fuchu F; Qin, Jun J; Ding, Chen C
Publication Date: 2023-02-14

Variant appearance in text: ERBB2: Val777Leu
PubMed Link: 36788224
Variant Present in the following documents:
  • 41467_2023_35797_MOESM4_ESM.xlsx, sheet 2
View BVdb publication page



Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.

Nature Communications
Harding, James J JJ; Piha-Paul, Sarina A SA; Shah, Ronak H RH; Murphy, Jessica J JJ; Cleary, James M JM; Shapiro, Geoffrey I GI; Quinn, David I DI; Braña, Irene I; Moreno, Victor V; Borad, Mitesh M; Loi, Sherene S; Spanggaard, Iben I; Park, Haeseong H; Ford, James M JM; Arnedos, Mónica M; Stemmer, Salomon M SM; de la Fouchardiere, Christelle C; Fountzilas, Christos C; Zhang, Jie J; DiPrimeo, Daniel D; Savin, Casey C; Duygu Selcuklu, S S; Berger, Michael F MF; Eli, Lisa D LD; Meric-Bernstam, Funda F; Jhaveri, Komal K; Solit, David B DB; Abou-Alfa, Ghassan K GK
Publication Date: 2023-02-06

Variant appearance in text: ERBB2: V777L
PubMed Link: 36746967
Variant Present in the following documents:
  • Main text
  • 41467_2023_36399_MOESM3_ESM.xlsx, sheet 5
  • 41467_2023_36399_MOESM2_ESM.pdf
  • 41467_2023_36399_MOESM1_ESM.pdf
  • 41467_2023_Article_36399.pdf
View BVdb publication page



Significance of logistic regression scoring model based on natural killer cell-mediated cytotoxic pathway in the diagnosis of colon cancer.

Frontiers In Immunology
Ye, Zhen Z; Zhang, Huanhuan H; Liang, Jianwei J; Yi, Shuying S; Zhan, Xianquan X
Publication Date: 2023

Variant appearance in text: N/A
PubMed Link: 36742322
Variant Present in the following documents:
View BVdb publication page



Mechanisms of neratinib resistance in HER2-mutant metastatic breast cancer.

Cancer Drug Resistance (Alhambra, Calif.)
Eli, Lisa D LD; Kavuri, Shyam M SM
Publication Date: 2022

Variant appearance in text: HER2: V777L
PubMed Link: 36627899
Variant Present in the following documents:
  • cdr-5-4-873.pdf
View BVdb publication page



Trastuzumab combined with irinotecan in patients with HER2-positive metastatic colorectal cancer: A phase II single-arm study and exploratory biomarker analysis.

Cancer Research And Treatment
Xu, Ting T; Wang, Xicheng X; Xin, Ying Y; Wang, Zhenghang Z; Gong, Jifang J; Zhang, Xiaotian X; Li, Yanyan Y; Ji, Congcong C; Sun, Yu Y; Zhao, Feilong F; Huang, Depei D; Bai, Yuezong Y; Li, Jian J; Shen, Lin L
Publication Date: 2022-12-23

Variant appearance in text: HER2: V777L
PubMed Link: 36550683
Variant Present in the following documents:
  • Main text
  • crt-2022-1058.pdf
View BVdb publication page



An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.

Frontiers In Immunology
Lin, Jing J; Liu, Jun J; Hao, Shi-Guang SG; Lan, Bin B; Zheng, Xiao-Bin XB; Xiong, Jia-Ni JN; Zhang, Ying-Qian YQ; Gao, Xuan X; Chen, Chuan-Ben CB; Chen, Ling L; Huang, Yu-Fang YF; Luo, Hong H; Yi, Yu-Ting YT; Yi, Xin X; Lu, Jian-Ping JP; Zheng, Xiong-Wei XW; Chen, Gang G; Wang, Xue-Feng XF; Chen, Yu Y
Publication Date: 2022

Variant appearance in text: ERBB2: 2329G>C; V777L
PubMed Link: 36505399
Variant Present in the following documents:
  • Table_2.xlsx, sheet 3
  • Table_2.xlsx, sheet 2
View BVdb publication page



Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.

Nature Communications
Flanagan, Dustin J DJ; Amirkhah, Raheleh R; Vincent, David F DF; Gundaz, Nuray N; Gentaz, Pauline P; Cammareri, Patrizia P; McCooey, Aoife J AJ; McCorry, Amy M B AMB; Fisher, Natalie C NC; Davis, Hayley L HL; Ridgway, Rachel A RA; Lohuis, Jeroen J; Leach, Joshua D G JDG; Jackstadt, Rene R; Gilroy, Kathryn K; Mariella, Elisa E; Nixon, Colin C; Clark, William W; Hedley, Ann A; Markert, Elke K EK; Strathdee, Douglas D; Bartholin, Laurent L; Redmond, Keara L KL; Kerr, Emma M EM; Longley, Daniel B DB; Ginty, Fiona F; Cho, Sanghee S; Coleman, Helen G HG; Loughrey, Maurice B MB; Bardelli, Alberto A; Maughan, Timothy S TS; Campbell, Andrew D AD; Lawler, Mark M; Leedham, Simon J SJ; Barry, Simon T ST; Inman, Gareth J GJ; van Rheenen, Jacco J; Dunne, Philip D PD; Sansom, Owen J OJ
Publication Date: 2022-12-07

Variant appearance in text: N/A
PubMed Link: 36477656
Variant Present in the following documents:
View BVdb publication page



Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors.

Elife
Kang, Minsu M; Na, Hee Young HY; Ahn, Soomin S; Kim, Ji-Won JW; Lee, Sejoon S; Ahn, Soyeon S; Lee, Ju Hyun JH; Youk, Jeonghwan J; Kim, Haesook T HT; Kim, Kui-Jin KJ; Suh, Koung Jin KJ; Lee, Jun Suh JS; Kim, Se Hyun SH; Kim, Jin Won JW; Kim, Yu Jung YJ; Lee, Keun-Wook KW; Yoon, Yoo-Seok YS; Kim, Jee Hyun JH; Chung, Jin-Haeng JH; Han, Ho-Seong HS; Lee, Jong Seok JS
Publication Date: 2022-12-08

Variant appearance in text: ERBB2: V777L
PubMed Link: 36476508
Variant Present in the following documents:
  • Main text
  • elife-78636.pdf
  • elife-78636-supp2.xlsx, sheet 4
View BVdb publication page



Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications
Boström, Martin M; Larsson, Erik E
Publication Date: 2022-11-17

Variant appearance in text: ERBB2: V777L
PubMed Link: 36396655
Variant Present in the following documents:
  • 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches.

Journal Of Personalized Medicine
Bontoux, Christophe C; Benzaquen, Jonathan J; Hofman, Véronique V; Heeke, Simon S; Hannetel, Paul P; Capela-Brosseau-Laborde, Pierre P; Marquette, Charles-Hugo CH; Ilié, Marius M; Hofman, Paul P
Publication Date: 2022-10-04

Variant appearance in text: HER2: V777L
PubMed Link: 36294789
Variant Present in the following documents:
  • jpm-12-01651.pdf
View BVdb publication page



Phenotypic plasticity and genetic control in colorectal cancer evolution.

Nature
Househam, Jacob J; Heide, Timon T; Cresswell, George D GD; Spiteri, Inmaculada I; Kimberley, Chris C; Zapata, Luis L; Lynn, Claire C; James, Chela C; Mossner, Maximilian M; Fernandez-Mateos, Javier J; Vinceti, Alessandro A; Baker, Ann-Marie AM; Gabbutt, Calum C; Berner, Alison A; Schmidt, Melissa M; Chen, Bingjie B; Lakatos, Eszter E; Gunasri, Vinaya V; Nichol, Daniel D; Costa, Helena H; Mitchinson, Miriam M; Ramazzotti, Daniele D; Werner, Benjamin B; Iorio, Francesco F; Jansen, Marnix M; Caravagna, Giulio G; Barnes, Chris P CP; Shibata, Darryl D; Bridgewater, John J; Rodriguez-Justo, Manuel M; Magnani, Luca L; Sottoriva, Andrea A; Graham, Trevor A TA
Publication Date: 2022-11

Variant appearance in text: ERBB2: V777L
PubMed Link: 36289336
Variant Present in the following documents:
  • 41586_2022_5311_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.

The Journal Of Pathology
Posner, Atara A; Prall, Owen Wj OW; Sivakumaran, Tharani T; Etemadamoghadam, Dariush D; Thio, Niko N; Pattison, Andrew A; Balachander, Shiva S; Fisher, Krista K; Webb, Samantha S; Wood, Colin C; DeFazio, Anna A; Wilcken, Nicholas N; Gao, Bo B; Karapetis, Christos S CS; Singh, Madhu M; Collins, Ian M IM; Richardson, Gary G; Steer, Christopher C; Warren, Mark M; Karanth, Narayan N; Wright, Gavin G; Williams, Scott S; George, Joshy J; Hicks, Rodney J RJ; Boussioutas, Alex A; Gill, Anthony J AJ; Solomon, Benjamin J BJ; Xu, Huiling H; Fellowes, Andrew A; Fox, Stephen B SB; Schofield, Penelope P; Bowtell, David D; Mileshkin, Linda L; Tothill, Richard W RW
Publication Date: 2022-10-26

Variant appearance in text: ERBB2: Val777Leu
PubMed Link: 36287571
Variant Present in the following documents:
  • PATH-259-81-s011.xlsx, sheet 2
  • PATH-259-81-s009.xlsx, sheet 2
View BVdb publication page



Genomic landscape of lung cancer in the young.

Frontiers In Oncology
Ruiz, Rossana R; Galvez-Nino, Marco M; Roque, Katia K; Montes, Jaime J; Nuñez, Maria M; Raez, Luis L; Sánchez-Gambetta, Sergio S; Jaúregui, Sandra S; Viale, Sandra S; Smith, Edward S ES; Pinto, Joseph A JA; Mas, Luis L
Publication Date: 2022

Variant appearance in text: ERBB2: V777L
PubMed Link: 36263208
Variant Present in the following documents:
  • DataSheet_2.pdf
View BVdb publication page



Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers.

Bmc Cancer
Wu, Huita H; Ji, Haonan H; Yang, Wenhui W; Zhang, Min M; Guo, Yifang Y; Li, Bangkai B; Wang, Jiayin J; Chen, Rongrong R; Chen, Yuan Y; Wang, Xin X
Publication Date: 2022-09-27

Variant appearance in text: ERBB2: V777L
PubMed Link: 36167530
Variant Present in the following documents:
  • 12885_2022_9922_MOESM5_ESM.xlsx, sheet 1
View BVdb publication page



The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA.

Breast (Edinburgh, Scotland)
Liu, Binliang B; Hu, Zheyu Z; Ran, Jialu J; Xie, Ning N; Tian, Can C; Tang, Yu Y; Ouyang, Quchang Q
Publication Date: 2022-10

Variant appearance in text: N/A
PubMed Link: 35926241
Variant Present in the following documents:
View BVdb publication page



ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer.

Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc
Grote, Isabel I; Bartels, Stephan S; Christgen, Henriette H; Radner, Martin M; Gronewold, Malte M; Kandt, Leonie L; Raap, Mieke M; Lehmann, Ulrich U; Gluz, Oleg O; Graeser, Monika M; Kuemmel, Sherko S; Nitz, Ulrike U; Harbeck, Nadia N; Kreipe, Hans H; Christgen, Matthias M
Publication Date: 2022-12

Variant appearance in text: ERBB2: V777L
PubMed Link: 35842479
Variant Present in the following documents:
  • Main text
  • 41379_2022_1130_MOESM1_ESM.pdf
  • 41379_2022_Article_1130.pdf
View BVdb publication page



Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.

Nature Communications
Havugimana, Pierre C PC; Goel, Raghuveera Kumar RK; Phanse, Sadhna S; Youssef, Ahmed A; Padhorny, Dzmitry D; Kotelnikov, Sergei S; Kozakov, Dima D; Emili, Andrew A
Publication Date: 2022-07-13

Variant appearance in text: ERBB2: 2329G>C; V777L
PubMed Link: 35831314
Variant Present in the following documents:
  • 41467_2022_31809_MOESM8_ESM.xlsx, sheet 3
View BVdb publication page



Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue.

Frontiers In Oncology
Loria, Rossella R; Vici, Patrizia P; Di Lisa, Francesca Sofia FS; Soddu, Silvia S; Maugeri-Saccà, Marcello M; Bon, Giulia G
Publication Date: 2022

Variant appearance in text: HER2: V777L
PubMed Link: 35814399
Variant Present in the following documents:
  • Main text
  • fonc-12-877380.pdf
View BVdb publication page



Poziotinib Inhibits HER2-Mutant-Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer.

Cancer Research
Kalra, Rashi R; Chen, Ching Hui CH; Wang, Junkai J; Salam, Ahmad Bin AB; Dobrolecki, Lacey E LE; Lewis, Alaina A; Sallas, Christina C; Yates, Clayton C CC; Gutierrez, Carolina C; Karanam, Balasubramanyam B; Anurag, Meenakshi M; Lim, Bora B; Ellis, Matthew J MJ; Kavuri, Shyam M SM
Publication Date: 2022-08-16

Variant appearance in text: ERBB2: V777L
PubMed Link: 35736563
Variant Present in the following documents:
  • Main text
  • can-21-3106_supplementary_data_suppsf6.pdf
  • 2928.pdf
View BVdb publication page



Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.

Nature Communications
Gounder, Mrinal M MM; Agaram, Narasimhan P NP; Trabucco, Sally E SE; Robinson, Victoria V; Ferraro, Richard A RA; Millis, Sherri Z SZ; Krishnan, Anita A; Lee, Jessica J; Attia, Steven S; Abida, Wassim W; Drilon, Alexander A; Chi, Ping P; Angelo, Sandra P D' SP; Dickson, Mark A MA; Keohan, Mary Lou ML; Kelly, Ciara M CM; Agulnik, Mark M; Chawla, Sant P SP; Choy, Edwin E; Chugh, Rashmi R; Meyer, Christian F CF; Myer, Parvathi A PA; Moore, Jessica L JL; Okimoto, Ross A RA; Pollock, Raphael E RE; Ravi, Vinod V; Singh, Arun S AS; Somaiah, Neeta N; Wagner, Andrew J AJ; Healey, John H JH; Frampton, Garrett M GM; Venstrom, Jeffrey M JM; Ross, Jeffrey S JS; Ladanyi, Marc M; Singer, Samuel S; Brennan, Murray F MF; Schwartz, Gary K GK; Lazar, Alexander J AJ; Thomas, David M DM; Maki, Robert G RG; Tap, William D WD; Ali, Siraj M SM; Jin, Dexter X DX
Publication Date: 2022-06-15

Variant appearance in text: N/A
PubMed Link: 35705558
Variant Present in the following documents:
View BVdb publication page



A novel treatment strategy of HER2-targeted therapy in combination with Everolimus for HR+/HER2- advanced breast cancer patients with HER2 mutations.

Translational Oncology
Ma, Jing J; Li, Xuelu X; Zhang, Qianran Q; Li, Ning N; Sun, Siwen S; Zhao, Shanshan S; Zhao, Zuowei Z; Li, Man M
Publication Date: 2022-07

Variant appearance in text: HER2: V777L
PubMed Link: 35523006
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects.

Cancer Research
Ishiyama, Noboru N; O'Connor, Matthew M; Salomatov, Andrei A; Romashko, Darlene D; Thakur, Shalabh S; Mentes, Ahmet A; Hopkins, Julia F JF; Frampton, Garrett M GM; Albacker, Lee A LA; Kohlmann, Anna A; Roberts, Christopher C; Buck, Elizabeth E
Publication Date: 2022-05-03

Variant appearance in text: HER2: V777L
PubMed Link: 35503682
Variant Present in the following documents:
  • Main text
  • 1531.pdf
View BVdb publication page



Acquired Concurrent EGFR T790M and Driver Gene Resistance From EGFR-TKIs Hampered Osimertinib Efficacy in Advanced Lung Adenocarcinoma: Case Reports.

Frontiers In Pharmacology
Zeng, Yue Y; Feng, Yuanqing Y; Fu, Guihua G; Jiang, Junlan J; Liu, Xiaohan X; Pan, Yue Y; Hu, Chunhong C; Liu, Xianling X; Wu, Fang F
Publication Date: 2022

Variant appearance in text: HER2: V777L
PubMed Link: 35462930
Variant Present in the following documents:
  • Main text
  • fphar-13-838247.pdf
View BVdb publication page



Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.

Cancer Medicine
Liu, Binliang B; Yi, Zongbi Z; Guan, Yanfang Y; Ouyang, Quchang Q; Li, Chunxiao C; Guan, Xiuwen X; Lv, Dan D; Li, Lixi L; Zhai, Jingtong J; Qian, Haili H; Xu, Binghe B; Ma, Fei F; Zeng, Yixin Y
Publication Date: 2022-07

Variant appearance in text: ERBB2: 2329G>C; V777L
PubMed Link: 35393784
Variant Present in the following documents:
  • CAM4-11-2767-s001.xlsx, sheet 1
View BVdb publication page



Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study.

Jto Clinical And Research Reports
Thompson, Jeffrey C JC; Aggarwal, Charu C; Wong, Janeline J; Nimgaonkar, Vivek V; Hwang, Wei-Ting WT; Andronov, Michelle M; Dibardino, David M DM; Hutchinson, Christoph T CT; Ma, Kevin C KC; Lanfranco, Anthony A; Moon, Edmund E; Haas, Andrew R AR; Singh, Aditi P AP; Ciunci, Christine A CA; Marmarelis, Melina M; D'Avella, Christopher C; Cohen, Justine V JV; Bauml, Joshua M JM; Cohen, Roger B RB; Langer, Corey J CJ; Vachani, Anil A; Carpenter, Erica L EL
Publication Date: 2022-04

Variant appearance in text: HER2: V777L
PubMed Link: 35392653
Variant Present in the following documents:
  • mmc3.xlsx, sheet 1
View BVdb publication page



A Comprehensive Survey of Genomic Mutations in Breast Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets.

Frontiers In Oncology
Zhou, Si S; Liu, Songming S; Zhao, Lijian L; Sun, Hai-Xi HX
Publication Date: 2022

Variant appearance in text: ERBB2: V777L
PubMed Link: 35387130
Variant Present in the following documents:
  • Table_2.xlsx, sheet 1
View BVdb publication page



Clinical characteristics and treatment outcomes of primary malignant melanoma of esophagus: a single center experience.

Bmc Gastroenterology
Kim, Tae-Se TS; Min, Byung-Hoon BH; Min, Yang Won YW; Lee, Hyuk H; Rhee, Poong-Lyul PL; Kim, Jae J JJ; Lee, Jun Haeng JH
Publication Date: 2022-03-29

Variant appearance in text: HER2: V777L
PubMed Link: 35351022
Variant Present in the following documents:
  • Main text
  • 12876_2022_Article_2235.pdf
View BVdb publication page



Understanding the activating mechanism of the immune system against COVID-19 by Traditional Indian Medicine: Network pharmacology approach.

Advances In Protein Chemistry And Structural Biology
Thirumal Kumar, D D; Shree Devi, M S MS; Udhaya Kumar, S S; Sherlin, Annie A; Mathew, Aishwarya A; Lakshmipriya, M M; Sathiyarajeswaran, P P; Gnanasambandan, R R; Siva, R R; Magesh, R R; George Priya Doss, C C
Publication Date: 2022

Variant appearance in text: ERBB2: V777L
PubMed Link: 35305722
Variant Present in the following documents:
  • mmc09-01-9780323992275.pdf
View BVdb publication page



Systematic review and meta-analysis of genomic alterations in acral melanoma.

Pigment Cell & Melanoma Research
Broit, Natasa N; Johansson, Peter A PA; Rodgers, Chloe B CB; Walpole, Sebastian T ST; Hayward, Nicholas K NK; Pritchard, Antonia L AL
Publication Date: 2022-05

Variant appearance in text: N/A
PubMed Link: 35229492
Variant Present in the following documents:
View BVdb publication page